Savara Inc Interest Expense
Savara Inc (SVRA) reported Interest Expense of $113.00 thousand for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2018-08-09
- Savara Inc interest expense for the quarter ending 2018-06-30 was $113.00K, a 78.10% decline year-over-year.
- Savara Inc interest expense for the quarter ending 2018-03-31 was $104.00K, a 57.55% decline year-over-year.
- Savara Inc interest expense for the quarter ending 2017-12-31 was $123.00K, a 49.80% decline year-over-year.
- Savara Inc interest expense for the quarter ending 2017-09-30 was $277.00K, a 45.79% increase year-over-year.
- Savara Inc interest expense for fiscal 2017 was $1.16M, a 156.86% increase from fiscal 2016.
- Savara Inc interest expense for fiscal 2016 was $452.00K, a 82.51% decline from fiscal 2015.
- Savara Inc interest expense for fiscal 2015 was $2.58M.
- Savara Inc interest expense for fiscal 2011 was $11.01K, a 575.87% increase from fiscal 2010.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed | Interest Expense 181 month | Interest Expense 184 month | Interest Expense 187 month | Interest Expense 190 month | Interest Expense 193 month | Interest Expense 196 month | Interest Expense 199 month | Interest Expense 202 month | Interest Expense 205 month | Interest Expense 208 month | Interest Expense 211 month | Interest Expense 214 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-06-30 | $113.00K 10-Q · filed 2018-08-09 | $217.00K 10-Q · filed 2018-08-09 | $340.00K derived: sum of 3 quarters · filed 2018-08-09 | $617.00K derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||||||||
| 2018-03-31 | $104.00K 10-Q · filed 2018-05-09 | $227.00K derived: sum of 2 quarters · filed 2018-05-09 | $504.00K derived: sum of 3 quarters · filed 2018-05-09 | $1.02M derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||||||||
| 2017-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $400.00K derived: sum of 2 quarters · filed 2018-03-14 | $916.00K derived: sum of 3 quarters · filed 2018-08-09 | $1.16M 10-K · filed 2018-03-14 | ||||||||||||||||
| 2017-09-30 | $277.00K 10-Q · filed 2017-11-08 | $793.00K derived: sum of 2 quarters · filed 2018-08-09 | $1.04M 10-Q · filed 2017-11-08 | $1.28M derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||||||||
| 2017-06-30 | $516.00K 10-Q · filed 2018-08-09 | $761.00K 10-Q · filed 2018-08-09 | $1.01M derived: sum of 3 quarters · filed 2018-08-09 | $1.20M derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||||||||
| 2017-03-31 | $245.00K 10-Q · filed 2018-05-09 | $178.00K 10-Q · filed 2017-05-09 | $490.00K derived: sum of 2 quarters · filed 2018-05-09 | $680.00K derived: sum of 3 quarters · filed 2018-05-09 | $687.00K derived: sum of 4 quarters · filed 2018-05-09 | |||||||||||||||
| 2016-12-31 | $245.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $435.00K derived: sum of 2 quarters · filed 2018-03-14 | $442.00K derived: sum of 3 quarters · filed 2018-03-14 | $452.00K 10-K · filed 2018-03-14 | $2.13M 10-K · filed 2017-03-06 | |||||||||||||||
| 2016-09-30 | $190.00K 10-Q · filed 2017-11-08 | $948.00K 10-Q · filed 2016-11-08 | $197.00K derived: sum of 2 quarters · filed 2017-11-08 | $207.00K 10-Q · filed 2017-11-08 | $1.98M 10-Q · filed 2016-11-08 | $3.20M derived: sum of 4 quarters · filed 2018-03-14 | ||||||||||||||
| 2016-06-30 | $7.00K 10-Q · filed 2017-08-09 | $512.00K 10-Q · filed 2016-08-09 | $17.00K 10-Q · filed 2017-08-09 | $1.03M 10-Q · filed 2016-08-09 | $3.01M derived: sum of 3 quarters · filed 2018-03-14 | $3.11M derived: sum of 4 quarters · filed 2018-03-14 | ||||||||||||||
| 2016-03-31 | $519.00K 10-Q · filed 2017-05-09 | $3.00M derived: sum of 2 quarters · filed 2018-03-14 | $3.10M derived: sum of 3 quarters · filed 2018-03-14 | $3.10M derived: sum of 4 quarters · filed 2018-03-14 | ||||||||||||||||
| 2015-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $2.58M derived: sum of 2 quarters · filed 2018-03-14 | $2.58M derived: sum of 3 quarters · filed 2018-03-14 | $2.58M 10-K · filed 2018-03-14 | $603.00K 10-K · filed 2016-03-14 | |||||||||||||||
| 2015-09-30 | $101.00K 10-Q · filed 2016-11-08 | $102.00K derived: sum of 2 quarters · filed 2016-11-08 | $102.00K 10-Q · filed 2016-11-08 | |||||||||||||||||
| 2015-06-30 | $1.00K 10-Q · filed 2016-08-09 | $1.00K 10-Q · filed 2016-08-09 | ||||||||||||||||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-06 | |||||||||||||||||||
| 2014-03-31 | $191.73K 10-Q · filed 2014-05-05 | |||||||||||||||||||
| 2013-12-31 | $191.73K 10-K · filed 2014-03-26 | |||||||||||||||||||
| 2013-09-30 | $191.73K 10-Q · filed 2013-11-04 | |||||||||||||||||||
| 2013-06-30 | $191.73K 10-Q · filed 2013-08-05 | |||||||||||||||||||
| 2013-03-31 | $191.73K 10-Q · filed 2013-05-15 | |||||||||||||||||||
| 2012-12-31 | $191.73K 10-K · filed 2013-03-19 | |||||||||||||||||||
| 2012-09-30 | $191.73K 10-Q · filed 2012-11-05 | |||||||||||||||||||
| 2012-06-30 | $191.73K 10-Q · filed 2012-08-06 | |||||||||||||||||||
| 2012-03-31 | $10.71K 10-Q · filed 2012-05-07 | $21.45K derived: sum of 2 quarters · filed 2012-05-07 | $21.72K derived: sum of 3 quarters · filed 2012-11-05 | $202.44K 10-Q · filed 2012-05-07 | ||||||||||||||||
| 2011-12-31 | $10.74K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-08 | $11.01K derived: sum of 2 quarters · filed 2012-11-05 | $11.01K 10-K · filed 2012-03-08 | $191.73K 10-K · filed 2012-03-08 | ||||||||||||||||
| 2011-09-30 | $272.00 10-Q · filed 2012-11-05 | $272.00 10-Q · filed 2012-11-05 | $180.99K 10-Q · filed 2011-11-08 | |||||||||||||||||
| 2011-06-30 | $180.72K 10-Q · filed 2011-08-08 | |||||||||||||||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-08 | $0.00 derived: sum of 2 quarters · filed 2012-03-08 | $1.63K 10-K · filed 2012-03-08 | |||||||||||||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $1.63K 10-Q · filed 2011-11-08 | ||||||||||||||||||
| 2010-06-30 | $1.63K 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |